X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (39) 39
male (36) 36
aged (32) 32
middle aged (30) 30
index medicus (25) 25
adult (17) 17
female (15) 15
oncology (15) 15
aged, 80 and over (12) 12
prostate cancer (12) 12
retrospective studies (12) 12
urology & nephrology (12) 12
neoplasm staging (10) 10
prognosis (10) 10
cancer (9) 9
treatment outcome (9) 9
follow-up studies (8) 8
prostate (8) 8
benign prostatic hyperplasia (7) 7
care and treatment (7) 7
urinary bladder neoplasms - surgery (7) 7
bladder cancer (6) 6
disease-free survival (6) 6
medicine & public health (6) 6
radical prostatectomy (6) 6
recurrence (6) 6
urinary bladder neoplasms - pathology (6) 6
urology (6) 6
analysis (5) 5
carcinoma (5) 5
chemotherapy (5) 5
community-based study (5) 5
japanese men (5) 5
kaplan-meier estimate (5) 5
lower urinary tract symptoms (5) 5
prostate-specific antigen - blood (5) 5
prostatectomy - methods (5) 5
prostatic neoplasms - blood (5) 5
prostatic neoplasms - pathology (5) 5
research (5) 5
risk factors (5) 5
antigen (4) 4
cross-sectional studies (4) 4
cystectomy (4) 4
isoflavones (4) 4
japan (4) 4
japan - epidemiology (4) 4
longitudinal studies (4) 4
natural history (4) 4
population (4) 4
proportional hazards models (4) 4
prostatic neoplasms - surgery (4) 4
radical cystectomy (4) 4
surveys and questionnaires (4) 4
survival (4) 4
therapy (4) 4
urinary bladder neoplasms - drug therapy (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
breast-cancer (3) 3
carcinoma, transitional cell - pathology (3) 3
case-control studies (3) 3
combination (3) 3
community‐based study (3) 3
daidzein (3) 3
equol (3) 3
feces - microbiology (3) 3
health aspects (3) 3
hyperplasia (3) 3
hypertrophy (3) 3
incidence (3) 3
japanese male (3) 3
kidney neoplasms - pathology (3) 3
longitudinal study (3) 3
medical colleges (3) 3
men (3) 3
metastasis (3) 3
multivariate analysis (3) 3
oncology, experimental (3) 3
pathological stage (3) 3
prevalence (3) 3
progression (3) 3
prostate - diagnostic imaging (3) 3
prostate - pathology (3) 3
prostate - surgery (3) 3
prostatectomy (3) 3
prostatic hyperplasia (3) 3
prostatic hyperplasia - epidemiology (3) 3
prostatic hyperplasia - pathology (3) 3
prostatic neoplasms - diagnosis (3) 3
quality of life (3) 3
risk (3) 3
sexual function (3) 3
soybean products (3) 3
surgery (3) 3
survival rate (3) 3
testosterone - blood (3) 3
transitional-cell carcinoma (3) 3
transitional-cell-carcinoma (3) 3
trial (3) 3
tumors (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of urology : official journal of the Japanese Urological Association, ISSN 0919-8172, 09/2019
Journal Article
Current Bladder Dysfunction Reports, ISSN 1931-7212, 6/2015, Volume 10, Issue 2, pp. 160 - 169
In this paper, we review reports related to naftopidil since 2011. Naftopidil was approved in Japan as a drug for lower urinary tract symptoms suggestive of... 
Medicine & Public Health | Geriatrics/Gerontology | Gynecology | Alpha-1D adrenergic receptor | Benign prostatic hyperplasia | Lower urinary tract symptoms | Urology | Naftopidil | Care and treatment | Prostate | Drug approval | Hypertrophy
Journal Article
by Petrylak, Daniel and Petrylak, Daniel P and de Wit, Ronald and Chi, Kim Nguyen and Chi, Kim N and Drakaki, Alexandra and Sternberg, Cora N and Nishiyama, Hiroyuki and Castellano, Daniel and Hussain, Syed and Fléchon, Aude and Bamias, Aristotelis and Yu, Evan Y and van der Heijden, Michiel S and Matsubara, Nobuaki and Alekseev, Boris and Necchi, Andrea and Géczi, Lajos and Ou, Yen-Chuan and Coskun, Hasan Senol and Su, Yu-Li and Su, Wen-Pin and Hegemann, Miriam and Percent, Ivor and Percent, Ivor J and Lee, Yun-Gyoo and Lee, Hyo Jin and Lee, Jae-Lyun and Tucci, Marcello and Semenov, Andrey and Laestadius, Fredrik and Peer, Avivit and Tortora, Giampaolo and Safina, Sufia Z and Safina, Sufia and del Muro, Xavier Garcia and Rodriguez-Vida, Alejo and Cicin, Irfan and Harputluoglu, Hakan and Widau, Ryan C and Liepa, Astra M and Walgren, Richard A and Hamid, Oday and Zimmermann, Annamaria H and Bell-McGuinn, Katherine M and Powles, Thomas and Wong, Suet-Lai Shirley and Tan, Thean Hsiang and Hovey, Elizabeth Jane and Clay, Timothy Dudley and Ng, Siobhan Su Wan and Rutten, Annemie and Machiels, Jean-Pascal and Dumez, Herlinde and Cheng, Susanna Yee-Shan and Ferrario, Cristiano and Sengeloev, Lisa and Jensen, Niels Viggo and Thibault, Constance and Laguerre, Brigitte and Joly, Florence and Flechon, Aude and Culine, Stéphane and Becht, Catherine and Niegisch, Günter and Stöckle, Michael and Grimm, Marc-Oliver and Gakis, Georgios and Schultze-Seemann, Wolfgang and Kalofonos, Haralambos and Mavroudis, Dimitrios and Papandreou, Christos and Karavasilis, Vasilis and Révész, Janos and Geczi, Lajos and Rosenbaum, Eli and Leibowitz-Amit, Raya and Kejzman, Daniel and Sarid, David and Scagliotti, Giorgio Vittorio and Bracarda, Sergio and Massari, Francesco and Osawa, Takahiro and Miyajima, Naoto and Shinohara, Nobuo and Fukuta, Fumimasa and Ohyama, Chikara and Obara, Wataru and Yamashita, Shinichi and Tomita, Yoshihiko and Kawai, Koji and Fukasawa, Satoshi and Oyama, Masafumi and Yonese, Junji and Nagata, Masayoshi and Uemura, Motohide and Nishimura, Kazuo and Kawakita, Mutsushi and Tsunemori, Hiroyuki and Hashine, Katsuyoshi and ... and RANGE Study Investigators and RANGE study investigators
The Lancet, ISSN 0140-6736, 11/2017, Volume 390, Issue 10109, pp. 2266 - 2277
Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed... 
BLADDER-CANCER | MEDICINE, GENERAL & INTERNAL | 2ND-LINE THERAPY | TRANSITIONAL-CELL-CARCINOMA | CISPLATIN | DOXORUBICIN | METHOTREXATE | VINBLASTINE | OPEN-LABEL | COMBINATION | ENDOTHELIAL GROWTH-FACTOR | Carcinoma, Transitional Cell - mortality | Prognosis | Humans | Middle Aged | Male | Neoplasm Invasiveness - pathology | Urinary Bladder Neoplasms - pathology | Adult | Female | Urinary Bladder Neoplasms - mortality | Double-Blind Method | Risk Assessment | Docetaxel | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Carcinoma, Transitional Cell - pathology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Internationality | Neoadjuvant Therapy - methods | Carcinoma, Transitional Cell - drug therapy | Survival Analysis | Aged | Neoplasm Staging | Antimitotic agents | Care and treatment | Carcinoma | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Cancer | Cytotoxicity | Oncology | Patients | Cancer therapies | Metastases | Angiogenesis | Chemotherapy | Platinum | Medical prognosis | Ligands | Clinical medicine | Urothelial carcinoma | Vascular endothelial growth factor | Apoptosis
Journal Article
LUTS: Lower Urinary Tract Symptoms, ISSN 1757-5664, 04/2019, Volume 11, Issue 2, pp. O38 - O41
Objective Post‐micturition dribble (PMD) is one of the post‐micturition lower urinary tract symptoms (LUTS). Although there have been many studies of LUTS in... 
lower urinary tract symptoms | post‐micturition dribble | aging male | Aging male | Lower urinary tract symptoms | Post-micturition dribble | VALIDATION | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | LUTS | post-micturition dribble | BOTHER
Journal Article
BMC UROLOGY, ISSN 1471-2490, 10/2019, Volume 19, Issue 1, pp. 1 - 7
Background Neuroendocrine (NE) cells may have an impact on the development and initial growth of benign prostatic hyperplasia (BPH) according to previous human... 
UROLOGY & NEPHROLOGY | Neuroendocrine cell | Prostatic hyperplasia | Spontaneously hypertensive rat | CARCINOMA | PROMOTES | Hypertension | Immunohistochemistry | Usage | Body weight | Comparative analysis | Prostate | Hypertrophy | Serotonin | Funding | Hyperplasia | Stroma | Aging | Software | Epithelium | Prostate cancer | Tumors
Journal Article
Modern Pathology, ISSN 0893-3952, 01/2013, Volume 26, Issue 1, pp. 117 - 124
Journal Article
Journal Article
Current Bladder Dysfunction Reports, ISSN 1931-7212, 6/2013, Volume 8, Issue 2, pp. 166 - 173
In the past, “clinical benign prostatic hyperplasia” was used as a term indicating urinary symptoms accompanied by benign prostatic hyperplasia. However, there... 
Benign prostatic hyperplasia | Medicine & Public Health | Urology/Andrology | Community-based study | Lower urinary tract symptoms | Natural history | Medical colleges
Journal Article
Advances in Urology, ISSN 1687-6369, 2017, Volume 2017, pp. 8541697 - 7
. To evaluate the distribution of neuroendocrine (NE) cells which may influence the development of benign prostatic hyperplasia (BPH) in the transition zone... 
Care and treatment | Research | Hyperplasia | Analysis | Risk factors | Quality of life
Journal Article